Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07811466 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mobile Application-Based Interventions for Cannabis Use in Young Adults With First Episode Psychosis

Study acronym: Mobile Health
StatusNot Yet Recruiting
PhaseNot applicable
Started2026-09-15
View on ClinicalTrials.gov ↗
Psychotic disorders affect approximately 4% of Canadians and have a significant impact on individuals' well-being, their families and social networks, and healthcare systems. The development of psychosis is explained by a complex interplay of genetic and environmental factors, including the use of psychoactive substances. Frequent cannabis use can contribute to the development of psychotic disorders. The prevalence of cannabis use disorder (CUD) in individuals with a first-episode psychosis (FEP) followed in Early Intervention Services (EIS) is 42-53%, well above that of the general population (\~3%). Cannabis use in individuals with psychosis is associated with increased symptom severity, higher rates of relapse and hospitalization, and poor psychosocial functioning. Standardized mobile app-based interventions offer a scalable and accessible solution. Our team developed and piloted CHAMPS (harm reduction) and iCanChange (use reduction/cessation) with favourable results: retention 82% (CHAMPS) and 84-86% (iCC), high satisfaction, and preliminary efficacy signals. The two pilot studies were targeting feasibility, this study is studying efficacy of the two app-based interventions (CHAMPS and iCanChange).
Trial Details
NCT Number NCT07811466
Lead Sponsor Centre hospitalier de l'Université de Montréal (CHUM)
Collaborators: Integrated University Health and Social Services Center of the Capitale-Nationale, Nova Scotia Health Authority, Centre Intégré de Santé et de Services Sociaux de la Montérégie-Centre, Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal, Ottawa Hospital Research Institute
Conditions First Episode Psychosis (FEP), Psychosis, Schizophreni-form Disorder, Dependence Addictive
Enrollment 550 participants
Start Date 2026-09-15
Primary Completion 2030-09-15 (estimated)
Study Completion 2031-04-15 (estimated)
Updated on ClinicalTrials.gov 2026-09-10